3/13/2014

The FDA has granted AngioDynamics expanded clearance for its AngioVac venous drainage device, designed to help eliminate blockages and clots in blood. The device, which was launched in October 2012, can now be used for as long as six hours of extracorporeal bypass.

Related Summaries